Immediate Impact
1 by Nobel laureates 1 from Science/Nature 55 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024 Standout
Works of Alison K. Wright being referenced
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alison K. Wright | 321 | 126 | 25 | 117 | 28 | 668 | |
| J. Lee | 255 | 207 | 18 | 99 | 18 | 750 | |
| Shajith Anoop | 228 | 141 | 5 | 92 | 29 | 697 | |
| Flavia Lombardo | 333 | 180 | 5 | 114 | 31 | 732 | |
| Ana González Hernández | 114 | 178 | 236 | 91 | 31 | 776 | |
| Shawn Bugden | 215 | 150 | 9 | 60 | 50 | 770 | |
| Konstantinos Michalakis | 206 | 247 | 55 | 81 | 23 | 849 | |
| Healani Chang | 240 | 127 | 29 | 151 | 23 | 734 | |
| A. K. Azad Khan | 292 | 188 | 12 | 73 | 22 | 689 | |
| Pandora L. Wander | 154 | 111 | 46 | 59 | 41 | 670 | |
| Carlos E. Mendez | 395 | 63 | 3 | 74 | 37 | 697 |
All Works
Login with ORCID to disown or claim papers
Loading papers...